Delivery Order SPE2DB24D2100-SPE2DB25FBDVP
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIMZELX 160 MG/ML AUTOINJECTORML. The contract has a firm fixed price of $9,783.88 and a completion date of May 22, 2025. The contract is not set aside and is for open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,765.98, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of July 3, 2024. The contract is not designated with any set-aside requirements, indicating open...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,476.69, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $36,199.65 and is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML medical products. The contract is a firm fixed-price delivery order, with a period of performance running through February 10, 2025. AmerisourceBergen is the prime contractor on...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BIMZELX 320 MG/2 ML AUTOINJECT 2ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price, non-set-aside agreement with a ceiling value of $13,795.65 and a period of performance through June 10, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,016.42 firm-fixed-price delivery order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $9,407.04 and an Ultimate Completion Date of April 9, 2025. The contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIMZELX 320 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with a ceiling value of $141,811.89 and a completion date of June 18, 2025. The contract is a firm-fixed-price delivery order, which means the price is set and will not change regardless of the contractor's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,292.36 Firm Fixed Price Delivery Order (SPE2DB22D2211) is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR, a specialty medication, with a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a $20,936.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIMZELX 320 MG/2 ML AUTOINJECT 2ML medical products. The contract has a performance period through June 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...